216
Views
4
CrossRef citations to date
0
Altmetric
Rheumatoid Arthritis

Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis

, , , , , , , , & show all
Pages 1079-1086 | Received 11 Sep 2020, Accepted 14 Jan 2021, Published online: 09 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chiara Jeiziner, Samuel S Allemann, Kurt E Hersberger & Henriette E Meyer zu Schwabedissen. (2022) Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report. Pharmacogenomics and Personalized Medicine 15, pages 465-475.
Read now

Articles from other publishers (3)

Yong Jiang, Shuxin Zhong, Shenghua He, Juanling Weng, Lijin Liu, Yufeng Ye & Hanwei Chen. (2023) Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of rheumatoid arthritis. Frontiers in Immunology 14.
Crossref
Zhuqian Wang, Jie Huang, Duoli Xie, Dongyi He, Aiping Lu & Chao Liang. (2021) Toward Overcoming Treatment Failure in Rheumatoid Arthritis. Frontiers in Immunology 12.
Crossref
Zhuo-Xun Wu, Yuqi Yang, Jing-Quan Wang, Silpa Narayanan, Zi-Ning Lei, Qiu-Xu Teng, Leli Zeng & Zhe-Sheng Chen. (2021) Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor. Frontiers in Cell and Developmental Biology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.